These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21266487)

  • 1. A cation-π interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists.
    Pless SA; Hanek AP; Price KL; Lynch JW; Lester HA; Dougherty DA; Lummis SC
    Mol Pharmacol; 2011 Apr; 79(4):742-8. PubMed ID: 21266487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cation-pi interaction in the binding site of the glycine receptor is mediated by a phenylalanine residue.
    Pless SA; Millen KS; Hanek AP; Lynch JW; Lester HA; Lummis SC; Dougherty DA
    J Neurosci; 2008 Oct; 28(43):10937-42. PubMed ID: 18945901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of a putative intersubunit electrostatic bond enhances agonist efficacy at the human α1 glycine receptor.
    Welsh BT; Todorovic J; Kirson D; Allen HM; Bayly MD; Mihic SJ
    Brain Res; 2017 Feb; 1657():148-155. PubMed ID: 27923639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The M4 transmembrane segment contributes to agonist efficacy differences between alpha1 and alpha3 glycine receptors.
    Chen X; Webb TI; Lynch JW
    Mol Membr Biol; 2009 Aug; 26(5):321-32. PubMed ID: 19626554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperekplexia mutations of the glycine receptor unmask the inhibitory subsite for beta-amino-acids.
    Laube B; Langosch D; Betz H; Schmieden V
    Neuroreport; 1995 Apr; 6(6):897-900. PubMed ID: 7542038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of glycine receptor subunit creates beta-alanine receptor responsive to GABA.
    Schmieden V; Kuhse J; Betz H
    Science; 1993 Oct; 262(5131):256-8. PubMed ID: 8211147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Novel Functionally Important Aromatic Residue Interactions in the Extracellular Domain of the Glycine Receptor.
    Tang B; Devenish SO; Lummis SCR
    Biochemistry; 2018 Jul; 57(27):4029-4035. PubMed ID: 29947514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential agonist sensitivity of glycine receptor alpha2 subunit splice variants.
    Miller PS; Harvey RJ; Smart TG
    Br J Pharmacol; 2004 Sep; 143(1):19-26. PubMed ID: 15302677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulation of the glycine receptor activated by agonists differing in efficacy.
    Farley NM; Mihic SJ
    Brain Res; 2015 May; 1606():95-101. PubMed ID: 25721789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a glycine receptor domain that controls the binding and gating mechanisms of the beta-amino acid agonist, taurine.
    Han NL; Haddrill JL; Lynch JW
    J Neurochem; 2001 Nov; 79(3):636-47. PubMed ID: 11701767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intracellular domain of homomeric glycine receptors modulates agonist efficacy.
    Ivica J; Lape R; Jazbec V; Yu J; Zhu H; Gouaux E; Gold MG; Sivilotti LG
    J Biol Chem; 2021; 296():100387. PubMed ID: 33617876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of the inhibitory glycine receptor: agonist and antagonist actions of amino acids and piperidine carboxylic acid compounds.
    Schmieden V; Betz H
    Mol Pharmacol; 1995 Nov; 48(5):919-27. PubMed ID: 7476923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic determinants of agonist action at the recombinant human glycine receptor.
    Lewis TM; Schofield PR; McClellan AM
    J Physiol; 2003 Jun; 549(Pt 2):361-74. PubMed ID: 12679369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonists.
    Rajendra S; Lynch JW; Pierce KD; French CR; Barry PH; Schofield PR
    Neuron; 1995 Jan; 14(1):169-75. PubMed ID: 7826634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational variability of the glycine receptor M2 domain in response to activation by different agonists.
    Pless SA; Dibas MI; Lester HA; Lynch JW
    J Biol Chem; 2007 Dec; 282(49):36057-67. PubMed ID: 17911099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two amino acid residues contribute to a cation-π binding interaction in the binding site of an insect GABA receptor.
    Lummis SC; McGonigle I; Ashby JA; Dougherty DA
    J Neurosci; 2011 Aug; 31(34):12371-6. PubMed ID: 21865479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations within the agonist-binding site convert the homomeric alpha1 glycine receptor into a Zn2+-activated chloride channel.
    Grudzinska J; Schumann T; Schemm R; Betz H; Laube B
    Channels (Austin); 2008; 2(1):13-8. PubMed ID: 18690053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrinsic factors regulate partial agonist efficacy of strychnine-sensitive glycine receptors.
    Farroni JS; McCool BA
    BMC Pharmacol; 2004 Aug; 4():16. PubMed ID: 15301692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple regions in the extracellular domain of the glycine receptor determine receptor activity.
    Tang B; Lummis SCR
    J Biol Chem; 2018 Sep; 293(36):13889-13896. PubMed ID: 29941455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel domain of the inhibitory glycine receptor determining antagonist efficacies: further evidence for partial agonism resulting from self-inhibition.
    Schmieden V; Kuhse J; Betz H
    Mol Pharmacol; 1999 Sep; 56(3):464-72. PubMed ID: 10462533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.